Skip to main content

We need more new antibiotics

By Helen Boucher, Special to CNN
updated 6:43 PM EDT, Thu June 13, 2013
STORY HIGHLIGHTS
  • Obama administration is considering streamlining the approval process for antibiotics
  • Helen Boucher: For patients with life-threatening infections, access to new antibiotics is vital
  • She says by limiting their use to the sickest of the sick, we can minimize risks of new drugs
  • Boucher: We need to encourage more companies to do antibiotic research and development

Editor's note: Helen Boucher is director of the infectious diseases fellowship program and staff physician at Tufts Medical Center, and associate professor of medicine at Tufts University School of Medicine. She is a member of the Infectious Diseases Society of America's Antimicrobial Resistance Committee and serves in advisory roles related to antibiotic development for some pharmaceutical companies.

(CNN) -- For desperately ill patients with serious, life-threatening antibiotic-resistant infections, access to new antibiotics is a matter of life and death.

All across America, people are dying from bacterial infections that we used to be able to cure with antibiotics.

Just this March, the Centers for Disease Control and Prevention warned the public about a four-fold increase in one group of "nightmare bacteria," carbapenem-resistant Enterobacteriaceae, which kills up to 50% of the people infected, and is on the rise. The annual impact of antibiotic resistant infections on the U.S. health care system is estimated to be $21 billion to $34 billion in excess health care costs and more than 8 million additional hospital days. At the same time, we are not making new antibiotics fast enough to prevent these deaths.

Without new antibiotics, things we all take for granted, including surgery, chemotherapy, organ transplantation and premature infant care, will be in jeopardy. A streamlined but targeted approach that speeds regulatory approval of new antibiotics -- and limits their use to the sickest of the sick -- is an appropriate way to balance the safety risks of these new drugs with the lifesaving benefits they can offer patients who have no other treatment options.

Helen Boucher
Helen Boucher

As a practicing infectious disease physician, my colleagues and I are seeing firsthand the devastating effects that resistant infections have on patients.

Consider Addie Rerecich, who was a healthy, athletic 11-year-old in 2011 before she spent five months in an Arizona hospital battling several serious drug-resistant infections that her doctors did not have antibiotics powerful enough to treat. Addie ultimately needed a double lung transplant to save her life. The health care costs from her hospital stay alone totaled $6 million, and she will need medical attention and therapy for the rest of her life.

As resistant infections like those that nearly took Addie's life continue to increase, the antibiotic pipeline is nearly dry, with few drugs in development that will work against the most alarming pathogens our patients face.

A proposal from the Infectious Diseases Society of America aims to address a key part of the problem by reducing the obstacles to regulatory approval of new antibiotics for use in a distinct, narrow group of people: Patients with serious resistant infections that have no effective treatment options left.

How will this make a difference?

The current regulatory environment in the U.S. discourages drug companies from antibiotic research and development, and few firms are active in this area today. Antibiotics also aren't as profitable as other drugs, such as those for chronic conditions like heart disease or diabetes, which patients often take for years. A more direct path for regulatory approval can encourage more companies to get involved in antibiotic development again.

IDSA's approach -- the Limited Population Antibacterial Drug -- would speed patients' access to new, lifesaving antibiotics by allowing the Food and Drug Administration to approve them for narrow use based on smaller clinical trials than required for more widely used antibiotics. Under LPAD, drug companies will still have to show that a drug's benefits outweigh the risks in patients with serious infections. It's an idea modeled after the successful Orphan Drug Program, which encourages the development of drugs for rare diseases.

Promoting the appropriate use of these new antibiotics is critical, because we know antibiotic misuse and overuse are significant drivers of drug resistance.

Special labeling will ensure narrow marketing of these drugs. Educational efforts should be put in place to send a strong signal to health care providers, facilities and insurers that these drugs are only for patients who need them most. These drugs will also likely be priced higher, commensurate with their value as life-saving medicines, than traditionally approved antibiotics, another factor that will help limit their wider use.

Antibiotic stewardship programs, which encourage appropriate antibiotic use by providers and health facilities, will play a key role. These programs provide much needed support and guidance to clinicians and ensure that our precious resource of antibiotics will be used wisely.

Professional medical groups -- including the American Medical Association -- public health organizations, patient groups and pharmaceutical manufacturers have voiced their support for IDSA's proposal. FDA and several members of Congress are also interested in the concept and in moving it forward.

To be sure, developing new antibiotics and speeding their approval process to treat seriously ill patients is just one way to grapple with this complex public health crisis.

IDSA also promotes enhanced public health efforts, including better data collection and surveillance of drug resistance and the use of antibiotics, improved infection prevention, antimicrobial stewardship, and stronger efforts to encourage the appropriate use of antibiotics in humans and on the farm. Increased research funding to explore how antibiotic resistance develops and spreads is just as vital, along with additional economic incentives and regulatory clarity to boost antibiotic development.

Patients like Addie need our help. We must take action now.

Follow @CNNOpinion on Twitter.

Join us at Facebook/CNNOpinion.

The opinions expressed in this commentary are solely those of Helen Boucher.

ADVERTISEMENT
Part of complete coverage on
updated 8:21 AM EDT, Mon September 1, 2014
Carlos Moreno says atheists, a sizable fraction of Americans, deserve representation in Congress.
updated 12:25 PM EDT, Sun August 31, 2014
Julian Zelizer says Democrats and unions have a long history of mutual support that's on the decline. But in a time of income inequality they need each other more than ever
updated 12:23 AM EDT, Sun August 31, 2014
William McRaven
Peter Bergen says Admiral William McRaven leaves the military with a legacy of strategic thinking about special operations
updated 12:11 PM EDT, Fri August 29, 2014
Leon Aron says the U.S. and Europe can help get Russia out of Ukraine by helping Ukraine win its just war, sharing defense technologies and intelligence
updated 1:24 PM EDT, Fri August 29, 2014
Timothy Stanley the report on widespread child abuse in a British town reveals an institutional betrayal by police, social services and politicians. Negligent officials must face justice
updated 9:06 PM EDT, Fri August 29, 2014
Peter Bergen and David Sterman say a new video of an American suicide bomber shows how Turkey's militant networks are key to jihadists' movement into Syria and Iraq. Turkey must stem the flow
updated 11:54 AM EDT, Mon September 1, 2014
Whitney Barkley says many for-profit colleges deceive students, charge exorbitant tuitions and make false promises
updated 10:34 AM EDT, Fri August 29, 2014
Mark O'Mara says the time has come to decide whether we really want police empowered to shoot those they believe are 'fleeing felons'
updated 10:32 AM EDT, Thu August 28, 2014
Bill Frelick says a tool of rights workers is 'naming and shaming,' ensuring accountability for human rights crimes in conflicts. But what if wrongdoers know no shame?
updated 10:43 PM EDT, Thu August 28, 2014
Jay Parini says, no, a little girl shouldn't fire an Uzi, but none of should have easy access to guns: The Second Amendment was not written to give us such a 'right,' no matter what the NRA says
updated 1:22 PM EDT, Sat August 30, 2014
Terra Ziporyn Snider says many adolescents suffer chronic sleep deprivation, which can indeed lead to safety problems. Would starting school an hour later be so wrong?
updated 9:30 AM EDT, Fri August 29, 2014
Peggy Drexler says after all the celebrity divorces, it's tempting to ask the question. But there are still considerable benefits to getting hitched
updated 2:49 PM EDT, Fri August 29, 2014
The death of Douglas McAuthur McCain, the first American killed fighting for ISIS, highlights the pull of Syria's war for Western jihadists, writes Peter Bergen.
updated 6:42 PM EDT, Tue August 26, 2014
Former ambassador to Syria Robert Ford says the West should be helping moderates in the Syrian armed opposition end the al-Assad regime and form a government to focus on driving ISIS out
updated 9:21 AM EDT, Wed August 27, 2014
Ruben Navarrette says a great country does not deport thousands of vulnerable, unaccompanied minors who fled in fear for their lives
updated 9:19 AM EDT, Wed August 27, 2014
Robert McIntyre says Congress is the culprit for letting Burger King pay lower taxes after merging with Tim Hortons.
updated 7:35 PM EDT, Tue August 26, 2014
Wesley Clark says the U.S. can offer support to its Islamic friends in the region most threatened by ISIS, but it can't fight their war
updated 4:53 PM EDT, Tue August 26, 2014
America's painful struggle with racism has often brought great satisfaction to the country's rivals, critics, and foes. The killing of Michael Brown and its tumultuous aftermath has been a bonanza.
updated 3:19 PM EDT, Tue August 26, 2014
Rick Martin says the death of Robin Williams brought back memories of his own battle facing down depression as a young man
updated 11:58 AM EDT, Tue August 26, 2014
David Perry asks: What's the best way for police officers to handle people with psychiatric disabilities?
updated 3:50 PM EDT, Mon August 25, 2014
Julian Zelizer says it's not crazy to think Mitt Romney would be able to end up at the top of the GOP ticket in 2016
updated 4:52 PM EDT, Mon August 25, 2014
Roxanne Jones and her girlfriends would cheer from the sidelines for the boys playing Little League. But they really wanted to play. Now Mo'ne Davis shows the world that girls really can throw.
updated 5:04 PM EDT, Mon August 25, 2014
Kimberly Norwood is a black mom who lives in an affluent neighborhood not far from Ferguson, but she has the same fears for her children as people in that troubled town do
updated 5:45 PM EDT, Fri August 22, 2014
It apparently has worked for France, say Peter Bergen and Emily Schneider, but carries uncomfortable risks. When it comes to kidnappings, nations face grim options.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT